TO BE LEAN OR NOT TO BE LEAN - IS LEPTIN THE ANSWER

Citation
Tw. Stephens et Jf. Caro, TO BE LEAN OR NOT TO BE LEAN - IS LEPTIN THE ANSWER, EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 106(1), 1998, pp. 1-15
Citations number
161
Categorie Soggetti
Endocrynology & Metabolism
ISSN journal
09477349
Volume
106
Issue
1
Year of publication
1998
Pages
1 - 15
Database
ISI
SICI code
0947-7349(1998)106:1<1:TBLONT>2.0.ZU;2-4
Abstract
Leptin and the leptin receptor genes have been identified as the site of mutations in the peripheral adipocyte hormone pathway responsible f or obesity in the ob/ob mouse (Zhang et al., 1994) and the db/db mouse (Chen et al., 1996). In obese humans, ob/ob like mutations in leptin are rare but confirm a role for leptin (Montague et al., 1997), and db /db like mutations in the leptin receptor have not been found (Considi ne et al., 1996a); however, the increased understanding of the molecul ar basis for obesity has generated tremendous interest among scientist s and patients alike. The new knowledge could be the base for intellig ent drugs for the treatment of obesity. Herein we will put in perspect ive a) the physiological background that led to the discovery of lepti n, b) leptin biosynthesis, c) leptin action and d) the clinical issues related to leptin as a drug for the treatment of obesity.